Funding for this research was provided by:
Fraunhofer-Gesellschaft (Anti-Corona 840245)
Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Institutsteil Bioanalytik und Bioprozesse des Fraunhofer IZI-BB
Received: 11 February 2022
Accepted: 15 July 2022
First Online: 27 July 2022
: DMS and CM are co-inventors on patent applications WO2018215660A1 and WO2020212576A1 currently pending, which cover the multivalent presentation of virus-binding peptides on DNA scaffolds. All other authors declare no potential conflict of interest.